Shizuko Harada

2.8k total citations · 1 hit paper
58 papers, 2.3k citations indexed

About

Shizuko Harada is a scholar working on Epidemiology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Shizuko Harada has authored 58 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Epidemiology, 22 papers in Oncology and 14 papers in Pathology and Forensic Medicine. Recurrent topics in Shizuko Harada's work include Viral-associated cancers and disorders (22 papers), Herpesvirus Infections and Treatments (20 papers) and Cytomegalovirus and herpesvirus research (12 papers). Shizuko Harada is often cited by papers focused on Viral-associated cancers and disorders (22 papers), Herpesvirus Infections and Treatments (20 papers) and Cytomegalovirus and herpesvirus research (12 papers). Shizuko Harada collaborates with scholars based in Japan, United States and Norway. Shizuko Harada's co-authors include Izumu Saito, Elliott Kieff, Yuichi Sato, Kenji Takamori, Yumi Kanegae, Shinji Miyake, Tatsuo Miyamura, Ryosuke Suzuki, Yasunori Watanabe and Ramana R. Yalamanchili and has published in prestigious journals such as Proceedings of the National Academy of Sciences, PLoS ONE and Molecular and Cellular Biology.

In The Last Decade

Shizuko Harada

56 papers receiving 2.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Efficient generation of recombinant adenoviruses using adenovirus DNA-terminal protein complex and a cosmid bearing the full-length virus genome.

1996 758 citations Shizuko Harada, Izumu Saito et al. profile →

Peers

Shizuko Harada

ONCOL

EPIDE

HEPAT

GENET

Michel A. Horisberger Switzerland

Nadir Mechti France

N Kitamura Japan

Bernard Gerrard United States

Yaël Mamane Canada

Mark Renz United States

Atsuo Ochi Canada

Chun Jeih Ryu South Korea

Esther Caparrós Spain

Daeyoup Lee South Korea

Michel A. Horisberger Switzerland

Shizuko Harada

926 ×1.0

580 ×0.8

ONCOL

637 ×1.1

EPIDE

186 ×0.4

HEPAT

274 ×0.7

GENET

Citations per year, relative to Shizuko Harada Shizuko Harada (= 1×) peers Michel A. Horisberger

Countries citing papers authored by Shizuko Harada

Since Specialization

Citations

This map shows the geographic impact of Shizuko Harada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shizuko Harada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shizuko Harada more than expected).

Fields of papers citing papers by Shizuko Harada

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shizuko Harada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shizuko Harada. The network helps show where Shizuko Harada may publish in the future.

Co-authorship network of co-authors of Shizuko Harada

This figure shows the co-authorship network connecting the top 25 collaborators of Shizuko Harada. A scholar is included among the top collaborators of Shizuko Harada based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shizuko Harada. Shizuko Harada is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Yamada, Souichi, Shizuko Harada, H Fujii, et al.. (2024). A Mutation in the Herpes Simplex Virus Type 1 (HSV-1) UL29 Gene is Associated with Anti-Herpesvirus Drugs’ Susceptibility. Viruses. 16(12). 1813–1813.

Yamada, Souichi, Harutaka Katano, Yuko Sato, et al.. (2023). Macacine alphaherpesvirus 1 (B Virus) Infection in Humans, Japan, 2019. Emerging infectious diseases. 30(1). 2 indexed citations

Fujii, H, Shuetsu Fukushi, Tomoki Yoshikawa, et al.. (2023). Pathological and virological findings of type I interferon receptor knockout mice upon experimental infection with Heartland virus. Virus Research. 340. 199301–199301. 3 indexed citations

Fujii, H, Hideki Tani, Satoshi Taniguchi, et al.. (2022). Susceptibility of Type I Interferon Receptor Knock-Out Mice to Heartland Bandavirus (HRTV) Infection and Efficacy of Favipiravir and Ribavirin in the Treatment of the Mice Infected with HRTV. Viruses. 14(8). 1668–1668. 12 indexed citations

Yoshikawa, Tomoki, Souichi Yamada, Takuya Inagaki, et al.. (2020). Association of human cytomegalovirus (HCMV) neutralizing antibodies with antibodies to the HCMV glycoprotein complexes. Virology Journal. 17(1). 120–120. 8 indexed citations

Yoshikawa, Tomoki, H Fujii, Akiko Okutani, et al.. (2018). Construction and characterization of bacterial artificial chromosomes harboring the full-length genome of a highly attenuated vaccinia virus LC16m8. PLoS ONE. 13(2). e0192725–e0192725. 6 indexed citations

Fujii, H, Tomoki Yoshikawa, Souichi Yamada, et al.. (2017). Association between sensitivity of viral thymidine kinase-associated acyclovir-resistant herpes simplex virus type 1 and virulence. Virology Journal. 14(1). 59–59. 8 indexed citations

Fujii, H, Satsuki Kakiuchi, Masanori Tsuji, et al.. (2017). Application of next-generation sequencing to detect acyclovir-resistant herpes simplex virus type 1 variants at low frequency in thymidine kinase gene of the isolates recovered from patients with hematopoietic stem cell transplantation. Journal of Virological Methods. 251. 123–128. 17 indexed citations

Muromoto, Ryuta, Osamu Ikeda, Sumihito Togi, et al.. (2008). Epstein–Barr virus-derived EBNA2 regulates STAT3 activation. Biochemical and Biophysical Research Communications. 378(3). 439–443. 34 indexed citations

10.

Gotoh, Eisuke, et al.. (2005). Telomere size and telomerase activity in Epstein-Barr virus (EBV)-positive and EBV-negative Burkitt’s lymphoma cell lines. Archives of Virology. 150(10). 2139–2150. 21 indexed citations

11.

Kim, Kwang-Rok, Tomokazu Yoshizaki, Hisashi Miyamori, et al.. (2000). Transformation of Madin-Darby canine kidney (MDCK) epithelial cells by Epstein-Barr virus latent membrane protein 1 (LMP1) induces expression of Ets1 and invasive growth. Oncogene. 19(14). 1764–1771. 90 indexed citations

12.

Suzuki, Ryosuke, Yu Matsuura, Tadaki Suzuki, et al.. (1995). Nuclear localization of the truncated hepatitis C virus core protein with its hydrophobic C terminus deleted. Journal of General Virology. 76(1). 53–61. 118 indexed citations

13.

Inoue, Yuki, Ryosuke Suzuki, Shizuko Harada, et al.. (1992). Expression of the amino-terminal half of the NS1 region of the hepatitis C virus genome and detection of an antibody to the expressed protein in patients with liver diseases. Journal of General Virology. 73(8). 2151–2154. 28 indexed citations

14.

Katayama, T, Toshio Mazda, Shu Kikuchi, et al.. (1992). Improved serodiagnosis of non-A, non-B hepatitis by an assay detecting antibody to hepatitis C virus core antigen. Hepatology. 15(3). 391–394. 34 indexed citations

15.

Inoue, Naoki, et al.. (1991). The domain of Epstein-Barr virus nuclear antigen 1 essential for binding to oriP region has a sequence fitted for the hypothetical basic-helix-loop-helix structure. Virology. 182(1). 84–93. 25 indexed citations

16.

Harada, Shizuko, et al.. (1991). Prevalence of antibody against the core protein of hepatitis C virus in patients with hepatocellular carcinoma. International Journal of Cancer. 48(3). 340–343. 30 indexed citations

17.

Inoue, Naoki, Shizuko Harada, N. Miyasaka, A. Oya, & Kazuhiro Yanagi. (1991). Analysis of Antibody Titers to Epstein-Barr Virus Nuclear Antigens in Sera of Patients with Sjogren's Syndrome and with Rheumatoid Arthritis. The Journal of Infectious Diseases. 164(1). 22–28. 37 indexed citations

18.

Harada, Shizuko, et al.. (1990). Epidemiologic Analysis of DNA's of Herpes Simplex Virus Type 1 and Type 2 Isolates Obtained from Family Members and from Different Lesions of Individuals. Kansenshogaku zasshi. 64(6). 674–680. 1 indexed citations

19.

Harada, Shizuko, et al.. (1989). Destabilization of herpes simplex virus type 1 virions by local anesthetics, alkaline pH, and calcium depletion. Archives of Virology. 108(1-2). 151–159. 8 indexed citations

20.

Yoshino, Kamesaburo, et al.. (1988). Molecular Epidemiology of Herpes Simplex Virus and Geographic Localization of a variant of Herpes Simplex Virus Type 1. Kansenshogaku zasshi. 62(6). 590–597. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact